Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

October 24, 2017

Study Completion Date

January 24, 2018

Conditions
AnemiaDialysis Dependent Chronic Kidney Disease
Interventions
DRUG

Vadadustat

Daily oral dose

DRUG

Placebo

Daily oral dose

Trial Locations (18)

Unknown

Aichi

Ehime

Fukui

Hiroshima

Hokkaido

Hyōgo

Ibaraki

Kagoshima

Kochi

Miyagi

Nagano

Nagasaki

Niigata

Okinawa

Osaka

Ōita

Saitama

Shizuoka

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY